Mylan Pharma Takes On Boehringer's Mirapex Patent
Mylan Pharmaceuticals Inc. is seeking to challenge German drug maker Boehringer Ingelheim International Gmbh for market share of Parkinson's disease drug Mirapex. That challenge prompted a federal lawsuit in which Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article